Page results
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
This page answers common questions about high-intensity focused ultrasound (HIFU) treatment for the prostate.
-
The UCLH Maternity Voices Partnership (MVP) is a team of women and their families, commissioners and providers (midwives and doctors) working together to review and contribute to the development of local maternity care.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
This page explains what to do and what to avoid when your child has had extractions or minor oral surgery.
-
This page has been written to tell you more about an outpatient hysteroscopy, why it is being done and what it involves.
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
We provide routine histopathological diagnoses using both standard techniques and advanced diagnostics including immunocytochemistry, fluoresent in-situ hybridisation (FISH), and polymerase chain…
-
RESPOND is a new rapid access, community-based screening and care planning system for all asylum-seeking families registered with a GP in North Central London.
-
National Patient Safety Alert Babies and young children (under five years) or children with additional needs, vulnerable adults and pets can suffer serious injury if they ingest coin/button batteries…
File results
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems
-
FOI/2023/0126 - Repayment fees for internationally recruited nurses
-
FOI/2023/0127 - Organisational structure for finance managers
-
FOI/2023/0131 - Training for first aid, life support, CPR and resuscitation/ defibrillator
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0155 - Patient transport policy
-
FOI/2023/0152 - Wheelchair associated services
-
FOI/2023/0122 - Usage of Pembrolizumab for the treatment of melanoma